Home › Trial NCT03445000
ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer
- Trial IDNCT03445000
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorETOP IBCSG Partners Foundation
- Enrollment14
- Start date2018-11-06
- ConditionsNon-small Cell Lung Cancer · Non-small Cell Lung Cancer Metastatic · Non-small Cell Lung Cancer Recurrent
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.